Principal Financial Group Inc. cut its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS – Free Report) by 20.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 402,098 shares of the company’s stock after selling 103,755 shares during the period. Principal Financial Group Inc.’s holdings in Addus HomeCare were worth $50,403,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Quarry LP bought a new stake in shares of Addus HomeCare during the third quarter worth about $28,000. Farther Finance Advisors LLC grew its position in Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after purchasing an additional 366 shares in the last quarter. KBC Group NV grew its position in Addus HomeCare by 49.1% in the 4th quarter. KBC Group NV now owns 814 shares of the company’s stock worth $102,000 after purchasing an additional 268 shares in the last quarter. Assetmark Inc. grew its position in Addus HomeCare by 11.5% in the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock worth $156,000 after purchasing an additional 121 shares in the last quarter. Finally, GAMMA Investing LLC grew its position in Addus HomeCare by 34.5% in the 4th quarter. GAMMA Investing LLC now owns 1,258 shares of the company’s stock worth $158,000 after purchasing an additional 323 shares in the last quarter. 95.35% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of equities research analysts have issued reports on ADUS shares. JMP Securities started coverage on shares of Addus HomeCare in a research report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price objective for the company. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research report on Thursday, November 14th. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. Oppenheimer boosted their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Finally, Stephens boosted their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $134.22.
Addus HomeCare Stock Down 1.0 %
ADUS opened at $112.07 on Friday. The stock has a market cap of $2.03 billion, a price-to-earnings ratio of 25.65, a PEG ratio of 1.47 and a beta of 1.00. The company’s 50-day moving average price is $125.35 and its two-hundred day moving average price is $126.81. Addus HomeCare Co. has a twelve month low of $85.94 and a twelve month high of $136.72.
Insider Activity at Addus HomeCare
In related news, EVP Roberton James Stevenson sold 2,250 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,236,257. This represents a 18.05 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the sale, the chief executive officer now owns 141,897 shares in the company, valued at $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 39,750 shares of company stock worth $4,930,750. 4.60% of the stock is owned by corporate insiders.
Addus HomeCare Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Articles
- Five stocks we like better than Addus HomeCare
- What is Short Interest? How to Use It
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- 3 REITs to Buy and Hold for the Long Term
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- EV Stocks and How to Profit from Them
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.